NANabieh Ayoub

Nabieh Ayoub

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nabieh Ayoub has a total of 73 co-authors. Here are the top co-authors by number of shared publications:

  • Feras E. Machour

    The Francis Crick Institute

    9 shared publications
  • Enas R. Abu-Zhayia

    Technion - Israel institute of Technology

    8 shared publications
  • Alma Sophia Barisaac

    Technion - Israel institute of Technology

    7 shared publications
  • Hanan Khoury-Haddad

    Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel

    5 shared publications
  • Laila A. Bishara

    Technion - Israel institute of Technology

    4 shared publications
  • Noga Guttmann-Raviv

    Schulich Faculty of Chemistry, Technion-Israel Institute of Technology, Haifa 3200008, Israel; Department of Biology, Technion-Israel Institute of Technology, Haifa 3200003, Israel

    4 shared publications

Latest Publications

  • Open Access

    LSm4 biomolecular condensates drive XRN2-mediated RNA decay at DNA double-strand breaks to facilitate repair

    by Malak M. Darawshe, Laila A. Bishara, Enas R. Abu-Zhayia, Alma Sophia Barisaac, Feras E. Machour, Christeen Elmor, Nabieh Ayoub

    Maintenance of genome integrity requires accurate repair of DNA double-strand breaks (DSBs), particularly within transcriptionally active regions. Persistent R-loops at DSBs can impede homologous recombination (HR) repair. While factors that resolve R-loops at DSB sites are known, the mechanisms ensuring timely degradation of nascent RNA to prevent pathological R-loop accumulation remain elusive. Here, we identified a critical role for the RNA-binding protein LSm4 in orchestrating localized RNA decay at DSBs to facilitate repair. We demonstrated that among LSm1-8 subunits, only LSm4 undergoes liquid-liquid phase separation (LLPS) and forms biomolecular condensates (BCs) specifically at DSBs in transcriptionally active chromatin. These damage-induced LSm4 BCs function as hubs that promote nuclear RNA decapping and recruit the 5′→3′ exonuclease XRN2 to degrade nascent transcripts proximal to DSBs. Accordingly, LSm4-XRN2 axis suppresses R-loop hyperaccumulation, thereby enabling efficient RAD51 filament assembly and intact HR repair. Consequently, loss of LSm4 increases translocations and leads to genomic instability. Collectively, our findings define a new regulatory layer in which LSm4 BCs spatially license RNA degradation, preventing R-loop accumulation at DSB microenvironment to facilitate error-free repair.

  • Open Access

    An antagonistically pleiotropic gene regulates vertebrate growth, maturity, and lifespan

    by Eitan Moses, Marva Bergman, Tehila Atlan, Elizabeth M. L. Duxbury, Roman Franěk, Omer Ben Dor, Henrik von Chrzanowski, Enas R. Abu-Zhayia, Nabieh Ayoub, Shay Kinreich, et al.

    The antagonistic pleiotropy theory of aging predicts genetic trade-offs between early-life and late-life fitness. However, empirical evidence for such trade-offs in vertebrates remains scarce, particularly from causal genetic experiments. Here, combining genetic perturbation with longitudinal phenotyping in the turquoise killifish (Nothobranchius furzeri), we identify vestigial-like 3 (vgll3), previously linked by GWAS to age at maturity in humans and male Atlantic salmon, as a gene with antagonistically pleiotropic effects. Selective disruption of vgll3 isoforms accelerates male growth and maturation in a dose-dependent manner. Transcriptomic and cellular analyses indicated increased cell division, corroborated in vivo by elevated germline and intestinal stem-cell proliferation. However, early-life maturation incurs a late-life cost, linked to altered DNA damage response. Older mutant males develop melanoma-like tumors, validated via transplantation into immunodeficient rag2 models, and exhibit a shortened lifespan. Thus, we identify vgll3 as a key regulator of life-history variation with antagonistic effects across ages, balancing early-life fitness against late-life mortality.


  • Open Access

    C8orf33 dictates DNA double-strand break repair choice by modulating KAT8-mediated H4K16 acetylation

    by Laila A. Bishara, Enas R. Abu-Zhayia, Marian Nicola, Nabieh Ayoub

    Homologous recombination (HR) and non-homologous end joining (NHEJ) are two main repair pathways of DNA double-strand breaks (DSBs). The regulation of repair pathway choice is crucial for maintaining genomic stability and preventing carcinogenesis. Consequently, there is increasing interest in elucidating the molecular mechanisms that govern DSB repair pathway selection. Here, we identify chromosome 8 open reading frame 33 (C8orf33) as a novel regulator of DSB repair choice. We show that C8orf33 is a nuclear protein localized predominantly to the nucleolus and is recruited to DSB sites within both nuclear and nucleolar regions. We demonstrate that C8orf33 promotes the recruitment of 53BP1, thus channeling DSB repair toward NHEJ. Consequently, C8orf33 inhibits DNA end resection and counteracts the recruitment of HR factors, BRCA1 and RAD51, to DSB sites. Mechanistically, chromatin profiling analysis reveals that C8orf33 antagonizes the chromatin association of KAT8 acetyltransferase at DSB sites leading to reduced histone 4 lysine 16 acetylation (H4K16ac) levels. Accordingly, the loss of C8orf33 enhances KAT8 chromatin binding that increases H4K16ac levels. This promotes the recruitment of HR factors while suppressing the accumulation of NHEJ factors at DSB sites, thereby favoring HR over NHEJ. Additionally, we demonstrate that the elevated HR activity in C8orf33-deficient cells causes genomic instability, as evidenced by accelerated loss of ribosomal DNA repeats and increases cell death. Collectively, our findings establish C8orf33 as a critical regulator of DSB repair pathway choice, safeguarding genomic integrity.


  • Open Access

    SLAYER: a computational framework for identifying synthetic lethal interactions through integrated analysis of cancer dependencies

    by Ziv Cohen, Ekaterina Petrenko, Alma Sophia Barisaac, Enas R Abu-Zhayia, Chen Yanovich-Ben-Uriel, Nabieh Ayoub, Dvir Aran

    Synthetic lethality represents a promising therapeutic approach in precision oncology, yet systematic identification of clinically relevant synthetic lethal interactions remains challenging. Here, we present SLAYER (Synthetic Lethality AnalYsis for Enhanced taRgeted therapy), a computational framework that integrates cancer genomic data and genome-wide CRISPR knockout screens to identify potential synthetic lethal interactions. SLAYER employs parallel analytical approaches examining both direct mutation-dependency associations and pathway-mediated relationships across 1080 cancer cell lines. Our integrative method identified 682 putative interactions, which were refined to 148 high-confidence candidates through stringent filtering for effect size, druggability, and clinical prevalence. Systematic validation against protein interaction databases revealed an ∼14-fold enrichment of known associations among SLAYER predictions compared with random gene pairs. Through pathway-level analysis, we identified inhibition of the aryl hydrocarbon receptor (AhR) as potentially synthetically lethal with RB1 mutations in bladder cancer. Experimental studies demonstrated selective sensitivity to AhR inhibition in RB1-mutant versus wild-type bladder cancer cells, which probably operates through indirect pathway-mediated mechanisms rather than direct genetic interaction. In summary, by integrating mutation profiles, gene dependencies, and pathway relationships, our approach provides a resource for investigating genetic vulnerabilities across cancer types.


  • Leveraging valine-restriction-induced DNA damage for targeted cancer therapy

    by Alma Sophia Barisaac, Enas R. Abu-Zhayia, Nabieh Ayoub


  • Why are RNA processing factors recruited to DNA double-strand breaks?

    by Feras E. Machour, Alma Sophia Barisaac, Nabieh Ayoub


  • Open Access

    Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma

    by Feras E. Machour, Enas R. Abu-Zhayia, Joyce Kamar, Alma Sophia Barisaac, Itamar Simon, Nabieh Ayoub

    The splicing factor RNA-binding motif protein 10 (RBM10) is frequently mutated in lung adenocarcinoma (LUAD) (9-25%). Most RBM10 cancer mutations are loss-of-function, correlating with increased tumorigenesis and limiting the efficacy of current LUAD targeted therapies. Remarkably, therapeutic strategies leveraging RBM10 deficiency remain unexplored. Here, we conduct a CRISPR-Cas9 synthetic lethality (SL) screen and identify ~60 RBM10 SL genes, including WEE1 kinase. WEE1 inhibition sensitizes RBM10-deficient LUAD cells in-vitro and in-vivo. Mechanistically, we identify a splicing-independent role of RBM10 in regulating DNA replication fork progression and replication stress response, which underpins RBM10-WEE1 SL. Additionally, RBM10 interacts with active DNA replication forks, relying on DNA Primase Subunit 1 (PRIM1) that synthesizes Okazaki RNA primers. Functionally, we demonstrate that RBM10 serves as an anchor for recruiting Histone Deacetylase 1 (HDAC1) to facilitate H4K16 deacetylation and R-loop homeostasis to maintain replication fork stability. Collectively, our data reveal a role of RBM10 in fine-tuning DNA replication and provide therapeutic arsenal for targeting RBM10-deficient tumors.


  • Open Access

    A dual role of RBM42 in modulating splicing and translation of CDKN1A/p21 during DNA damage response

    by Bella M. Ben-Oz, Feras E. Machour, Marian Nicola, Amir Argoetti, Galia Polyak, Rawad Hanna, Oded Kleifeld, Yael Mandel-Gutfreund, Nabieh Ayoub

    P53-mediated cell cycle arrest during DNA damage is dependent on the induction of p21 protein, encoded by the CDKN1A gene. p21 inhibits cyclin-dependent kinases required for cell cycle progression to guarantee accurate repair of DNA lesions. Hence, fine-tuning of p21 levels is crucial to preserve genomic stability. Currently, the multilayered regulation of p21 levels during DNA damage is not fully understood. Herein, we identify the human RNA binding motif protein 42 (RBM42) as a regulator of p21 levels during DNA damage. Genome-wide transcriptome and interactome analysis reveals that RBM42 alters the expression of p53-regulated genes during DNA damage. Specifically, we demonstrate that RBM42 facilitates CDKN1A splicing by counteracting the splicing inhibitory effect of RBM4 protein. Unexpectedly, we also show that RBM42, underpins translation of various splicing targets, including CDKN1A. Concordantly, transcriptome-wide mapping of RBM42-RNA interactions using eCLIP further substantiates the dual function of RBM42 in regulating splicing and translation of its target genes, including CDKN1A. Collectively, our data show that RBM42 couples splicing and translation machineries to fine-tune gene expression during DNA damage response.


  • Recruitment of RBM6 to DNA Double-Strand Breaks Fosters Homologous Recombination Repair

    by Samah W. Awwad, Malak M. Darawshe, Feras E. Machour, Inbar Arman, Nabieh Ayoub

    DNA double-strand breaks (DSBs) are highly toxic lesions that threaten genome integrity and cell survival. To avoid harmful repercussions of DSBs, a wide variety of DNA repair factors are recruited to execute DSB repair. Previously, we demonstrated that RBM6 splicing factor facilitates homologous recombination (HR) of DSB by regulating alternative splicing-coupled nonstop-decay of the HR protein APBB1/Fe65. Here, we describe a splicing-independent function of RBM6 in promoting HR repair of DSBs. We show that RBM6 is recruited to DSB sites and PARP1 activity indirectly regulates RBM6 recruitment to DNA breakage sites. Deletion mapping analysis revealed a region containing five glycine residues within the G-patch domain that regulates RBM6 accumulation at DNA damage sites. We further ascertain that RBM6 interacts with Rad51, and this interaction is attenuated in RBM6 mutant lacking the G-patch domain (RBM6del(G-patch)). Consequently, RBM6del(G-patch) cells exhibit reduced levels of Rad51 foci after ionizing radiation. In addition, while RBM6 deletion mutant lacking the G-patch domain has no detectable effect on the expression levels of its splicing targets Fe65 and Eya2, it fails to restore the integrity of HR. Altogether, our results suggest that RBM6 recruitment to DSB promotes HR repair, irrespective of its splicing activity.


  • Open Access

    Harnessing DNA replication stress to target RBM10 deficiency in lung adenocarcinoma

    by Feras E. Machour, Enas Abu-Zhayia, Joyce Kamar, Alma Sophia Barisaac, Itamar Simon, Nabieh Ayoub

    The splicing factor RBM10 is frequently mutated in lung adenocarcinoma (LUAD) (9-25%). Most RBM10 cancer mutations are loss-of-function, correlating with increased tumorigenesis and limiting targeted therapy efficacy in EGFR-mutated lung cancer. Notably, therapeutic strategies leveraging RBM10 deficiency remain unexplored. Hence, we conducted RBM10 CRISPR-Cas9 synthetic lethality (SL) screen and identified ∼250 RBM10 SL genes, including WEE1 kinase. WEE1 inhibition sensitized RBM10-deficient LUAD cells in-vitro and in-vivo . Mechanistically, we identified a splicing-independent role of RBM10 in promoting replication fork progression that underpins RBM10-WEE1 SL. Also, we revealed that RBM10 is associated with active replication forks, which is reliant on PRIM1, an enzyme synthesizing RNA primers for Okazaki fragments. Functionally, we demonstrated that RBM10 serves as an anchor for recruiting HDAC1 and facilitates H4K16 deacetylation to maintain replication fork stability. Collectively, our data revealed a hitherto unrecognized function of RBM10 in fine-tuning DNA replication, and provide therapeutic arsenal for targeting RBM10-deficient tumors.